City Drug House Exporters | Hepatitis Medicines Supplier to Washington, USA, INDIA
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
Entaliv 0.5 is an antiviral medication used to treat chronic Hepatitis B virus (HBV) infection. Its active ingredient is Entecavir, a nucleoside reverse transcriptase inhibitor (NRTI) that suppresses viral replication in the liver, slowing the progression of liver damage.
Mechanism of Action :
Entecavir is converted to its active triphosphate form in the body. This active form combats the virus by inhibiting the Hepatitis B viral DNA polymerase enzyme at three distinct steps:
1.Inhibiting the priming of the HBV-DNA polymerase.
2.Blocking reverse transcription of the negative strands of HBV-DNA.
3.Stopping the synthesis of the positive strand of HBV-DNA.
Pharmacokinetics
Absorption: It is rapidly absorbed, and peak plasma concentrations are reached within 0.5 to 1.5 hours. It is recommended to be taken on an empty stomach (at least 2 hours before or after a meal) for optimal absorption.
Protein Binding: Approximately 13% bound to human serum proteins.
Metabolism: Undergoes minimal phase I metabolism. It is primarily converted intracellularly to its active form.
Half-life: The terminal elimination half-life is approximately 128 to 149 hours.
Excretion: Primarily excreted unchanged by the kidneys. Dosage adjustments are required for patients with renal impairment.
Usage and Precautions
Dosage: The typical adult dose is 0.5 mg once daily, taken on an empty stomach.Important
Warning: Entaliv 0.5 is not a cure for Hepatitis B and does not prevent the transmission of the virus to others. Discontinuing the medication abruptly can lead to severe acute exacerbations of Hepatitis.
Monitoring: Regular liver function tests, viral load assessments, and kidney function monitoring are strictly required during treatment.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House Exporters supplies and exports high-quality hepatitis medicines from India to Washington, USA with trusted pharma solutions and timely global delivery.
Entaliv 0.5 is an antiviral medication used to treat chronic Hepatitis B virus (HBV) infection. Its active ingredient is Entecavir, a nucleoside reverse transcriptase inhibitor (NRTI) that suppresses viral replication in the liver, slowing the progression of liver damage.
Mechanism of Action :
Entecavir is converted to its active triphosphate form in the body. This active form combats the virus by inhibiting the Hepatitis B viral DNA polymerase enzyme at three distinct steps:
1.Inhibiting the priming of the HBV-DNA polymerase.
2.Blocking reverse transcription of the negative strands of HBV-DNA.
3.Stopping the synthesis of the positive strand of HBV-DNA.
Pharmacokinetics
Absorption: It is rapidly absorbed, and peak plasma concentrations are reached within 0.5 to 1.5 hours. It is recommended to be taken on an empty stomach (at least 2 hours before or after a meal) for optimal absorption.
Protein Binding: Approximately 13% bound to human serum proteins.
Metabolism: Undergoes minimal phase I metabolism. It is primarily converted intracellularly to its active form.
Half-life: The terminal elimination half-life is approximately 128 to 149 hours.
Excretion: Primarily excreted unchanged by the kidneys. Dosage adjustments are required for patients with renal impairment.
Usage and Precautions
Dosage: The typical adult dose is 0.5 mg once daily, taken on an empty stomach.Important
Warning: Entaliv 0.5 is not a cure for Hepatitis B and does not prevent the transmission of the virus to others. Discontinuing the medication abruptly can lead to severe acute exacerbations of Hepatitis.
Monitoring: Regular liver function tests, viral load assessments, and kidney function monitoring are strictly required during treatment.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
